SEC Form 4 · accession 0001144204-17-035606
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark T Wagner
Director
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 2:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.37 | Jun 30, 2017 | A | 90,000 | A | — | Jun 30, 2027 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1The option vests in eleven equal monthly installments with one-eleventh (1/11) vesting on the thirtieth (30th) day of each of the next eleven (11) months (or, if there is no 30th day in a month, on the last day of that month), with the first such vesting date occurring on July 30, 2017, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan.